3 Stocks to Buy for Lifetime Income: Pfizer, Coca-Cola and Nvidia's Secret

Global stock markets are seeking companies with long-term value creation potential. James Brumley, analyst at The Motley Fool, analyzed three stocks in 2026 that could provide lifetime income. Pfizer (PFE), the pharmaceutical giant, is pivoting to develop 8 new blockbuster drugs by 2030 after overcoming COVID-19 challenges. Coca-Cola (KO), with its 64-year uninterrupted dividend increase streak, remains the most reliable income source in the sector. Nvidia's 2009 'Double Down' signal is lighting up again in 2026. These stocks are standing out with inflation-resistant strategies and innovation. How will markets react to this?

Pfizer's Comeback Story

■6.9% dividend yield attracting new investors

■8 blockbuster drugs target by 2030

■Metsera acquisition positioning in obesity drug market

■Padcev and other oncology drugs strengthening healthcare sector

Coca-Cola's 64-Year Dividend Record

■Uninterrupted dividend increase streak

■19.6% share in supermarkets

■Sustainability initiatives targeting new consumers

Nvidia's 2009 Signal

■Company 1/100th the size of Nvidia grew 100x in 10 years

■AI and data center chips market dominance

■2026 'Total Conviction' signal reigniting interest

How will markets respond to the long-term potential of these stocks? Pfizer's drug development power, Coca-Cola's dividend record, and Nvidia's AI leadership—will they shape the stock markets in 2026? Global supply chain crises and inflation shocks—how will they impact these companies' performance?